STAT Plus: Plasma giant Grifols to buy Silicon Valley startup targeting blood proteins for age-related diseases

The plasma processing company Grifols agreed to buy Alkahest, a Silicon Valley startup that’s betting that proteins in plasma can fight diseases including Alzheimer’s and Parkinson’s.

Click to view original post